Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Beclazone 100 inhaler
0302000C0BFABAB
|
Beclazone | Beclometasone dipropionate | Respiratory System | 1 |
|
Beclazone 100 Easi-Breathe inhaler
0302000C0BFAEAT
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 200 inhaler
0302000C0BFAGAR
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 250 Easi-Breathe inhaler
0302000C0BFAFAU
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 250 inhaler
0302000C0BFACAC
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 50 Easi-Breathe inhaler
0302000C0BFADAS
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
|
Beclazone 50 inhaler
0302000C0BFAAAA
|
Beclazone | Beclometasone dipropionate | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.